A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma
Young, R Poyser, C Crack, L Dockrell, D Bowman, C Billingham, L Bower, M Westwell, S Leahy, Michael G Woll, P
Young, R
Poyser, C
Crack, L
Dockrell, D
Bowman, C
Billingham, L
Bower, M
Westwell, S
Leahy, Michael G
Woll, P
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma. 2015, 51 S699-S699 Eur J Cancer